Back to Top
Bersanlimab Biosimilar - Research Grade
$710.00 - $6,900.00
Bersanlimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
ICAM1ï؟½
Concentration
5mg/ml
Isotype
IgG1 - lambda2
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P05362;P13597
Shipping Conditions
Blue ice
Background
Intercellular adhesion molecule 1 (ICAM1/CD54) mediates leukocyte adhesion and transmigration and is a recurring target in inflammation and vascular-biology research. This product is an unconjugated, non-therapeutic analog of bersanlimab, a human IgG1-lambda recombinant antibody supplied for research use only. It is an ultra-pure, low-endotoxin preparation built to in vivo standards and produced in scalable milligram-to-gram quantities for bulk and high-throughput laboratories. Applications include functional and adhesion assays, leukocyte-trafficking studies, in vitro screening and preclinical models that interrogate ICAM-1-dependent inflammatory processes. As a research-use-only reagent, it combines a low-endotoxin in vivo-grade format with scalable milligram-to-gram production for demanding studies.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












